Skip to content

Bio-Techne TECH Proceeds Payments From Equity Method Investment Dividends Or Distributions Return Of Capital

Proceeds Payments From Equity Method Investment Dividends Or Distributions Return Of Capital at other companies

SS&C Technologies logo
SS&C TechnologiesSSNC
$30.3M+3,267%
SS&C Technologies logo
SS&C TechnologiesSSNC
$30.3M+3,267%
TKO Group Holdings logo
TKO Group HoldingsTKO
$4.25K-96.5%
CF Industries logo
CF IndustriesCF
$40M
BWX Technologies logo
BWX TechnologiesBWXT
$4.84M-81.7%
CareTrust logo
CareTrustCTRE
$15.58M+16.1%

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$9.07B-11.8%
Enterprise value$9.15B-13.6%
P/E60.6×+13.6×
P/S7.5×-1.0×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept tech:ProceedsPaymentsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital.

The official record: Bio-Techne’s 10-K, filed August 22, 2025, on SEC EDGAR. View the filing →

Ask your AI about Bio-Techne's proceeds payments from equity method investment dividends or distributions return of capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Techne's proceeds payments from equity method investment dividends or distributions return of capital?
Bio-Techne (TECH) reported proceeds payments from equity method investment dividends or distributions return of capital of $1.82M in Q2 2025.
How has Bio-Techne's proceeds payments from equity method investment dividends or distributions return of capital changed year-over-year?
Bio-Techne's proceeds payments from equity method investment dividends or distributions return of capital increased by 4.2% year-over-year, from $1.75M to $1.82M.
What is the long-term trend for Bio-Techne's proceeds payments from equity method investment dividends or distributions return of capital?
Over 2 years (2023 to 2025), Bio-Techne's proceeds payments from equity method investment dividends or distributions return of capital has grown at a -82.3% compound annual growth rate (CAGR), from -$232M to $7.29M.
What does proceeds payments from equity method investment dividends or distributions return of capital mean?
Cash received from or paid to equity-method business partners.
How do you interpret proceeds payments from equity method investment dividends or distributions return of capital?
Higher inflows indicate successful performance of strategic partnerships or joint ventures.
How does proceeds payments from equity method investment dividends or distributions return of capital compare across companies?
Varies significantly based on the company's specific strategic partnership portfolio.